Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Locus Cell CoROCO:6891 -0.50%22 PB Ratio is 5.13 as of Aug. 13, 2026, which is 51% above its 10-year median of 3.39. GuruFocus rates ROCO:6891 with a GF Score™ of 22/100 and a GF Value™ of NT$778.63 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,220 Biotechnology companies, Locus Cell Co ranks worse than 69.51% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-13), Locus Cell Co's share price is NT$39.80. Locus Cell Co's Book Value per Share for the quarter that ended in Dec. 2025 was NT$7.75. Hence, Locus Cell Co's PB Ratio of today is 5.13.
The historical rank and industry rank for Locus Cell Co's PB Ratio or its related term are showing as below:
ROCO:6891'
s PB Ratio Range Over the Past 10 Years
Min: 2.08 Med: 3.39 Max: 10.11
Current: 5.13
During the past 6 years, Locus Cell Co's highest PB Ratio was 10.11. The lowest was 2.08. And the median was 3.39.
ROCO:6891's PB Ratio is ranked worse than 69.51% of 1220
companies
in the Biotechnology industry
Industry Median: 2.905
vs ROCO:6891: 5.13
During the past 12 months, Locus Cell Co's average Book Value Per Share Growth Rate was -10.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -6.80% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 182.00% per year.
During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Locus Cell Co was 1122.20% per year. The lowest was -6.80% per year. And the median was -4.30% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Locus Cell Co PB Ratio Related Terms
Locus Cell Co PB Ratio Historical Data
* Premium members only.
The historical data trend for Locus Cell Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6891 vs VRTX, REGN, RVMD: PB Ratio Comparison
For the Biotechnology subindustry, Locus Cell Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Locus Cell Co PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Locus Cell Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Locus Cell Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Locus Cell Co's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Locus Cell Co (ROCO:6891) has a PB Ratio of 5.13 as of Aug. 13, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Locus Cell Co and its competitors. This is 51% above median its historical median of 3.39. Over the past decade, Locus Cell Co's PB Ratio has ranged from 2.08 to 10.11. According to the industry distribution chart, Locus Cell Co ranks #848 out of 1220 companies in the Biotechnology industry, placing it in the top 69.5%.
Is Locus Cell Co's PB Ratio too high?
Locus Cell Co's current PB Ratio of 5.13 is 51% above median its 10-year median of 3.39. Over the past 10 years, this metric has ranged from a low of 2.08 to a high of 10.11. The Biotechnology industry median PB Ratio is 2.91. Locus Cell Co's value of 5.13 is 76.6% above this industry median. Based on the distribution chart, Locus Cell Co ranks #848 out of 1220 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Locus Cell Co has a GF Score™ of 22/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Locus Cell Co's PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Locus Cell Co ranks #848 out of 1220 companies for PB Ratio. This places Locus Cell Co in the lower half of its industry. The industry median PB Ratio is 2.91. Locus Cell Co's value of 5.13 is 76.6% above this benchmark. Historically, Locus Cell Co's own PB Ratio has ranged from 2.08 to 10.11 over the past decade. While the company's 10-year median is 3.39 vs. the industry median of 2.91, Locus Cell Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.91, based on 1,220 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Locus Cell Co's current PB Ratio of 5.13 is 76.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Locus Cell Co and its competitors. For the Biotechnology industry, the median PB Ratio is 2.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Locus Cell Co's current PB Ratio is 5.13, which is 51% above median its own 10-year median of 3.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Locus Cell Co stock overvalued right now?
Based on GuruFocus' analysis, Locus Cell Co (ROCO:6891) is currently considered Possible Value Trap. The stock's GF Value™ is NT$778.63, compared to a current price of NT$39.80 — trading 94.9% below its estimated fair value. The current PB Ratio is 5.13, which is 51% above median its 10-year median of 3.39 and 76.6% above the Biotechnology industry median of 2.91. Locus Cell Co's overall GF Score™ is 22/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Locus Cell Co (ROCO:6891), the current PB Ratio is 5.13 as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Locus Cell Co (ROCO:6891) Overvalued in 2026?
Based on GuruFocus' analysis, Locus Cell Co stock appears to be undervalued.
The current stock price of NT$39.80 is trading 94.9% below its estimated GF Value™ of NT$778.63.
GuruFocus considers Locus Cell Co to be Possible Value Trap.
Key valuation signals for ROCO:6891:
PB Ratio: 5.13 (51% above median its 10-year median of 3.39)
GF Value™: NT$778.63 vs. price of NT$39.80 (94.9% below fair value)
Industry Position: 76.6% above the Biotechnology median (#848 of 1220)
No single metric tells the full story. See the ROCO:6891 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6891 has been successfully added to your 
